Five core ADME genes coding for phase II drug metabolism enzymes showed significant associations of their intratumoral expression levels with OS rates in cancers, including GSTP1, NAT1, UGT1A1, UGT2B15, UGT2B7 (Figure 3, Table 2). The gene discussed is GSTP1; the disease is cancer.